EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intracameral Chemotherapy (Melphalan) for Aqueous Seeding in Retinoblastoma: Bicameral Injection Technique and Related Toxicity in a Pilot Case Study

Francis L Munier, Marie-Claire Gaillard, Sarah Decembrini, Massimo Bongiovanni, Maja Beck-Popovic

Ocular Oncology and Pathology · 2017 · 3 (2) · 149-155

DOI: 10.1159/000453617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 29.12.2016. Verfasst von Francis L Munier und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jules-Gonin Eye Hospital, University of Lausanne, Switzerland. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The anterior chamber has been shown by pharmacokinetic studies to represent a sanctuary never achieving a tumoricidal dose with the present administration routes, such as systemic, intra-arterial, or intravitreal injections.

Method

A novel intracameral chemotherapy technique is described to control aqueous seeding in a pilot unilateral group E retinoblastoma case with primary aqueous seeding. Anterior segment toxicity was carefully monitored.

Results

Control of the retinal tumor and vitreous seeding was achieved by intra-arterial and intravitreal chemotherapies. Sterilization of the aqueous was achieved after a first cycle of 7 melphalan injections in the anterior chamber, but relapse was noted 3.5 months later. This relapse was finally controlled with a second cycle of 6 intracameral injections targeting the posterior chamber. Corneal endothelial cell density remained stable over the injection period. Heterochromia and a progressive cataract developed, which required cataract surgery. At 5 years' follow-up, the patient is tumor free with normal vision (20/20 in both eyes), full binocularity, and no metastasis.

Conclusions

The present bicameral injection technique appears to be safe and effective with limited toxicity. Melphalan-induced side effects were noted on the iris and lens but with no impact on the final visual function.

Schlagwörter

Stichwörter der Autor:innen

Anterior chamber fluidAqueous seedingChemotherapyIntracameral chemotherapyIntravitreal injectionMelphalanPathology of the anterior segmentRetinoblastoma

Autor:innen und Institutionen

  • Jules-Gonin Eye Hospital, University of Lausanne, Switzerland.
  • Institute of Pathology, University of Lausanne, Switzerland.
  • Unit of Pediatric Hematology-Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Zitieren

APA

Munier, F. L., Gaillard, M. C., Decembrini, S., Bongiovanni, M., & Beck-Popovic, M. (2017). Intracameral Chemotherapy (Melphalan) for Aqueous Seeding in Retinoblastoma: Bicameral Injection Technique and Related Toxicity in a Pilot Case Study. Ocular Oncology and Pathology, 3(2), 149-155. https://doi.org/10.1159/000453617

Vancouver

Munier FL, Gaillard MC, Decembrini S, Bongiovanni M, Beck-Popovic M. Intracameral Chemotherapy (Melphalan) for Aqueous Seeding in Retinoblastoma: Bicameral Injection Technique and Related Toxicity in a Pilot Case Study. Ocular Oncology and Pathology. 2017;3(2):149-155. doi:10.1159/000453617

BibTeX
@article{Munier2017,
  author = {Munier, Francis L and Gaillard, Marie-Claire and Decembrini, Sarah and Bongiovanni, Massimo and Beck-Popovic, Maja},
  title = {Intracameral Chemotherapy (Melphalan) for Aqueous Seeding in Retinoblastoma: Bicameral Injection Technique and Related Toxicity in a Pilot Case Study},
  journal = {Ocular Oncology and Pathology},
  year = {2017},
  volume = {3},
  number = {2},
  pages = {149--155},
  doi = {10.1159/000453617}
}
Kostenlos starten →